Your browser doesn't support javascript.
loading
Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial.
Raal, Frederick J; Honarpour, Narimon; Blom, Dirk J; Hovingh, G Kees; Xu, Feng; Scott, Rob; Wasserman, Scott M; Stein, Evan A.
Afiliación
  • Raal FJ; Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
  • Honarpour N; Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA, USA.
  • Blom DJ; Division of Lipidology, Department of Medicine, University of Cape Town, UCT Faculty Health Sciences, Cape Town, South Africa.
  • Hovingh GK; Vascular Medicine, Academic Medical Centre, Amsterdam, Netherlands.
  • Xu F; Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA, USA.
  • Scott R; Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA, USA.
  • Wasserman SM; Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA, USA.
  • Stein EA; Metabolic and Atherosclerosis Research Center, Cincinnati, OH, USA. Electronic address: esteinmrl@aol.com.
Lancet ; 385(9965): 341-50, 2015 Jan 24.
Article en En | MEDLINE | ID: mdl-25282520

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proproteína Convertasas / Hiperlipoproteinemia Tipo II / Anticuerpos Monoclonales / Anticolesterolemiantes Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2015 Tipo del documento: Article País de afiliación: Sudáfrica

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proproteína Convertasas / Hiperlipoproteinemia Tipo II / Anticuerpos Monoclonales / Anticolesterolemiantes Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2015 Tipo del documento: Article País de afiliación: Sudáfrica